Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 5Sarcoma 3Gynecologic 3Gastrointestinal 3Endocrine 3Genitourinary 2Dermatologic 2CNS 2Breast 2Thoracic 1Other solid neoplasm 1NET 1

Conditions

Melanoma 346Carcinoma, Non-Small-Cell Lung 81Skin Neoplasms 71Carcinoma, Renal Cell 51Lung Neoplasms 49Neoplasm Metastasis 47Breast Neoplasms 45Colorectal Neoplasms 44Neoplasms 42Carcinoma, Basal Cell 42Uveal Melanoma 38Squamous Cell Carcinoma of Head and Neck 37Carcinoma, Merkel Cell 36Ovarian Neoplasms 35Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 26Prostatic Neoplasms 24Carcinoma, Hepatocellular 23Stomach Neoplasms 21Head and Neck Neoplasms 21Uterine Cervical Neoplasms 20Urinary Bladder Neoplasms 20Thyroid Neoplasms 20Esophageal Neoplasms 19Brain Neoplasms 18Carcinoma, Squamous Cell 17Mycosis Fungoides 16Carcinoma, Transitional Cell 16Triple Negative Breast Neoplasms 15

Interventions

Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Imatinib Mesylate 1Cyclophosphamide 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Adenoid Cystic × Dermatologic × 90 days × Clear all
NCT02834013 2026-06-03

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
798 enrolled
CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Nasopharyngeal Carcinoma, Bile Duct Neoplasms, Carcinoma, Basal Cell, Adenocarcinoma, Bronchiolo-Alveolar, Adenocarcinoma, Mucinous, Carcinoma, Transitional Cell, Carcinosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Gallbladder Neoplasms, Hemangiosarcoma, Mouth Neoplasms, Paget Disease, Extramammary, Paraganglioma, Paranasal Sinus Neoplasms, Parathyroid Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Thyroid Neoplasms, Vulvar Neoplasms, Desmoid Tumors, Seminoma, Carcinoma, Acinar Cell, Adrenocortical Carcinoma, Carcinoma, Endometrioid, Cholangiocarcinoma, Cystadenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Carcinoma, Giant Cell, Neurofibrosarcoma, Gestational Trophoblastic Disease, Rare Diseases, Gastrointestinal Stromal Tumors, Perivascular Epithelioid Cell Neoplasms

NCT01046487 2026-03-13

PALANGI3

Centre Oscar Lambret

Phase 1 Completed
26 enrolled
DermatologicGastrointestinalSarcoma

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡